Literature DB >> 2860065

Effects of transmission-blocking monoclonal antibodies on different isolates of Plasmodium falciparum.

P M Graves, R Carter, T R Burkot, J Rener, D C Kaushal, J L Williams.   

Abstract

The strain diversity in Plasmodium falciparum has been studied with respect to gamete surface antigens which are the targets of transmission-blocking antibodies. Of 12 isolates tested, 11 were positive by immunofluorescence with the three monoclonal antibodies studied. The exception was a Liberian isolate, two clones of which were found to react with only one of the three monoclonal antibodies. Antibodies IIC5-B10 and IA3-B8, which previously have been shown to act synergistically to block infectivity of 7G8, a Brazilian clone of P. falciparum, acted in an exactly similar way with another Brazilian isolate, It.D12, and an isolate from Thailand. In the presence of complement either IA3-B8 or a third antibody, IID2-A10, strongly suppressed infectivity of It.D12 as well as 7G8, but neither isolate was strongly suppressed by IIC5-B10. IA3-B8 and IID2-A10 did not react by immunofluorescence or immunoprecipitation with gametes of L.E5; IIC5-B10 reacted positively with L.E5 gametes in these tests. In the absence of complement, the combination of IA3-B8 and IIC5-B10 did not suppress infectivity of L.E5 to mosquitoes. In contrast to its effect on gametocytes of other isolates, IIC5-B10 in the presence of complement strongly suppressed infectivity of L.E5 to mosquitoes. These results imply that IA3-B8 and IIC5-B10 react with two structurally distinct epitopes on the surface of gametes of P. falciparum and that the properties of both epitopes on gametes of L.E5 differ from those on gametes of the other isolates tested.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860065      PMCID: PMC261204          DOI: 10.1128/iai.48.3.611-616.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  6 in total

1.  Drug sensitivity and isoenzyme type in cloned lines of Plasmodium falciparum.

Authors:  P M Graves; R Carter; J S Keystone; D C Seeley
Journal:  Am J Trop Med Hyg       Date:  1984-03       Impact factor: 2.345

2.  Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate.

Authors:  T R Burkot; J L Williams; I Schneider
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

3.  Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. I. Zygote surface antigens.

Authors:  D C Kaushal; R Carter; R J Howard; F M McAuliffe
Journal:  Mol Biochem Parasitol       Date:  1983-05       Impact factor: 1.759

4.  Complete in vitro maturation of Plasmodium falciparum gametocytes.

Authors:  T Ifediba; J P Vanderberg
Journal:  Nature       Date:  1981-11-26       Impact factor: 49.962

5.  Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes.

Authors:  D C Kaushal; R Carter; J Rener; C A Grotendorst; L H Miller; R J Howard
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

6.  Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum.

Authors:  J Rener; P M Graves; R Carter; J L Williams; T R Burkot
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

  6 in total
  11 in total

Review 1.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

2.  Two apparently nonrepeated epitopes on gametes of Plasmodium falciparum are targets of transmission-blocking antibodies.

Authors:  R Carter; G Bushell; A Saul; P M Graves; C Kidson
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

3.  Naturally occurring antibodies to an epitope on Plasmodium falciparum gametes detected by monoclonal antibody-based competitive enzyme-linked immunosorbent assay.

Authors:  P M Graves; R A Wirtz; R Carter; T R Burkot; M Looker; G A Targett
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

Review 4.  Status of malaria vaccine research.

Authors:  G A Targett
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

5.  Demonstration of antigenic polymorphism in Plasmodium vivax malaria with a panel of 30 monoclonal antibodies.

Authors:  P V Udagama; P H David; J S Peiris; Y G Ariyaratne; K L Perera; K N Mendis
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

6.  Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans.

Authors:  K N Mendis; Y D Munesinghe; Y N de Silva; I Keragalla; R Carter
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

7.  Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa.

Authors:  Brandyce St Laurent; Becky Miller; Timothy A Burton; Chanaki Amaratunga; Sary Men; Siv Sovannaroth; Michael P Fay; Olivo Miotto; Robert W Gwadz; Jennifer M Anderson; Rick M Fairhurst
Journal:  Nat Commun       Date:  2015-10-20       Impact factor: 14.919

8.  Transmission blocking immunity in Plasmodium vivax malaria: antibodies raised against a peptide block parasite development in the mosquito vector.

Authors:  V A Snewin; S Premawansa; G M Kapilananda; L Ratnayaka; P V Udagama; D M Mattei; E Khouri; G Del Giudice; J S Peiris; K N Mendis; P H David
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

9.  Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response.

Authors:  R R Dinglasan; J S Armistead; J F Nyland; X Jiang; H Q Mao
Journal:  Curr Mol Med       Date:  2013-05       Impact factor: 2.222

Review 10.  Complement in malaria: immune evasion strategies and role in protective immunity.

Authors:  Patience Kerubo Kiyuka; Seppo Meri; Ayman Khattab
Journal:  FEBS Lett       Date:  2020-04-01       Impact factor: 3.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.